Peripheral amylin modulation rebalances brain glycolysis and Tau-Ser214 phosphorylation via cAMP-PKA signaling. [PDF]
Davargaon RS +14 more
europepmc +1 more source
For Weight Loss: Why Do GLP-1 Agonists Work, and How Can We Make Them Work Better? [PDF]
Giang C +5 more
europepmc +1 more source
Emerging pharmacological targets in migraine therapy: CGRP and beyond. [PDF]
Atraszkiewicz D, Dahiya D.
europepmc +1 more source
Understanding the Metabolic and Endocrine Effects of Macronutrient Boluses in the Context of a Low-Carbohydrate Diet: A Randomized Crossover Study. [PDF]
Deru LS +5 more
europepmc +1 more source
Combination Pharmacotherapies for Obesity-Current Evidence and Future Directions. [PDF]
Kamrul-Hasan ABM +6 more
europepmc +1 more source
Obesity pharmacotherapy reimagined: The era of multi-receptor agonists and next-generation metabolic modulators, perspectives and controversies. [PDF]
Lempesis IG, Dalamaga M.
europepmc +1 more source
Recent developments in GPCR signalling in appetite regulation. [PDF]
Brittain HR, Gorvin CM.
europepmc +1 more source
Oral Health Implications of GLP-1 Receptor Agonists and Other Incretin-Based Therapies. [PDF]
Bijoch J.
europepmc +1 more source
Amylin-based obesity therapy: a meta-analysis of Cagrilintide and CagriSema versus placebo. [PDF]
Yaseen M +12 more
europepmc +1 more source
Hypothalamus-liver talks: whispers in the language of metabolism. [PDF]
Ferreira V +5 more
europepmc +1 more source

